Caricamento...
Clinicopathologic Features of Breast Cancer Reclassified as HER2-Amplified by Fluorescence In Situ Hybridization with Alternative Chromosome 17 Probes
OBJECTIVE: Dual probe fluorescence in situ hybridization (FISH) assays for determination of human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer provide a ratio of HER2 to chromosome 17. The ratio may be skewed by copy number alterations (CNA) in the control locus for...
Salvato in:
| Pubblicato in: | Ann Diagn Pathol |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7907993/ https://ncbi.nlm.nih.gov/pubmed/32805517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.anndiagpath.2020.151576 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|